Factoring Prior Treatment into Tuberculosis Infection Prevalence Estimates, United States, 2011–2012

To refine estimates of how many persons in the United States are candidates for treatment of latent tuberculosis, we removed from analysis persons who self-reported prior treatment on the National Health and Nutrition Examination Survey 2011–2012. We estimate that 12.6 million persons could benefit...

Descripción completa

Detalles Bibliográficos
Autores principales: Vonnahme, Laura A., Haddad, Maryam B., Navin, Thomas R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2019
Materias:
Dispatch
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6759264/
https://www.ncbi.nlm.nih.gov/pubmed/31538921
http://dx.doi.org/10.3201/eid2510.190439
_version_ 1783453668200153088
author Vonnahme, Laura A.
Haddad, Maryam B.
Navin, Thomas R.
author_facet Vonnahme, Laura A.
Haddad, Maryam B.
Navin, Thomas R.
author_sort Vonnahme, Laura A.
collection PubMed
description To refine estimates of how many persons in the United States are candidates for treatment of latent tuberculosis, we removed from analysis persons who self-reported prior treatment on the National Health and Nutrition Examination Survey 2011–2012. We estimate that 12.6 million persons could benefit from treatment to prevent active tuberculosis.
format Online
Article
Text
id pubmed-6759264
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-67592642019-10-02 Factoring Prior Treatment into Tuberculosis Infection Prevalence Estimates, United States, 2011–2012 Vonnahme, Laura A. Haddad, Maryam B. Navin, Thomas R. Emerg Infect Dis Dispatch To refine estimates of how many persons in the United States are candidates for treatment of latent tuberculosis, we removed from analysis persons who self-reported prior treatment on the National Health and Nutrition Examination Survey 2011–2012. We estimate that 12.6 million persons could benefit from treatment to prevent active tuberculosis. Centers for Disease Control and Prevention 2019-10 /pmc/articles/PMC6759264/ /pubmed/31538921 http://dx.doi.org/10.3201/eid2510.190439 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Dispatch
Vonnahme, Laura A.
Haddad, Maryam B.
Navin, Thomas R.
Factoring Prior Treatment into Tuberculosis Infection Prevalence Estimates, United States, 2011–2012
title Factoring Prior Treatment into Tuberculosis Infection Prevalence Estimates, United States, 2011–2012
title_full Factoring Prior Treatment into Tuberculosis Infection Prevalence Estimates, United States, 2011–2012
title_fullStr Factoring Prior Treatment into Tuberculosis Infection Prevalence Estimates, United States, 2011–2012
title_full_unstemmed Factoring Prior Treatment into Tuberculosis Infection Prevalence Estimates, United States, 2011–2012
title_short Factoring Prior Treatment into Tuberculosis Infection Prevalence Estimates, United States, 2011–2012
title_sort factoring prior treatment into tuberculosis infection prevalence estimates, united states, 2011–2012
topic Dispatch
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6759264/
https://www.ncbi.nlm.nih.gov/pubmed/31538921
http://dx.doi.org/10.3201/eid2510.190439
work_keys_str_mv AT vonnahmelauraa factoringpriortreatmentintotuberculosisinfectionprevalenceestimatesunitedstates20112012
AT haddadmaryamb factoringpriortreatmentintotuberculosisinfectionprevalenceestimatesunitedstates20112012
AT navinthomasr factoringpriortreatmentintotuberculosisinfectionprevalenceestimatesunitedstates20112012

Ejemplares similares